Vivoryon Therapeutics N.V. Stock: price and insider trades · Netherlands

Every trade that managers of Vivoryon Therapeutics N.V. disclose to AFM is tracked on this page. The company sits in the Healthcare & Pharma sector. In the past year (18 October 2025 to 18 October 2026), 10 filings came from 7 insiders.

Only purchases show up on the open market, 6 purchases in all worth €289k, filed by 5 insiders. No amount is published for 4 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 5 senior executives. E. Platzer filed the largest purchase, €233k, on 8 December 2025.

Compared with its exchange (126 companies, median 7 filings), a count of 10 filings is above the norm. Over the whole record (from 2020), the tally stands at 37 purchases and 3 sales.

In all, 1 purchase was made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 14 October 2026, 4 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from AFM. Past trades are no guide to future returns.